Australia's drug regulator has warned doctors to carefully weigh up the risk of suicidal thoughts in children taking ADHD drug Strattera after two children were reported to have tried to take their own lives and a nine-year-old boy took his own life.
This week, Australia's Therapeutic Goods Administration said that it had received 28 reports of suicidal thoughts in both teenagers and children as young as seven after taking ADHD drug Strattera.
Strattera was approved in Australia in 2004 and added to the country's Pharmaceutical Benefits Scheme in 2007. Pharmaceutical company Lilly is the manufacturer of Strattera.
Approximately 6000 Australian children were on Strattera in 2011. In the United States- 351,000 children are being prescribed Stattera and 7,900 of them are aged 0-5 years old. Sixteen drug regulatory agencies have issued warnings from six countries (United States, Australia, Ireland, United Kingdom, Canada and Russia) and the European Union.
A non-medical program,Brain Balance has been successful in helping thousands of kids who suffer with ADD/ADHD, Dyslexia, Tourette’s Syndrome, Asperger’s Syndromeand Autism Spectrum Disorders, reach their physical, social/behavioral health and academic potential. See: http://www.examiner.com/article/is-your-child-s-brain-balanced-chiropractic-neurologist-s-program-helps-kids
Don't miss another article. Subscribe to email alerts here: http://www.examiner.com/healthy-living-in-miami/jeannie-stokowski-bisanti